The company has two Phase 3 data releases for Paltusotine in treating acromegaly over the next 7-8 months. Acromegaly is a disorder caused by excess levels of growth hormone, and current ...

For informational purposes only. Consult a medical professional for advice. Source: Focus Medica. A rare condition which results from excessive production of growth hormone by the pituitary gland ...

Jeison Rodriguez Hernandez, a 28-year-old Venezuelan man with the world's largest feet, received custom-made shoes from a ...

It also helps to increase metabolism and burn fat. However, long-term high HGH levels can lead to acromegaly, a rare condition where your body overproduces growth hormones. This condition might be ...

Late-Breaking Presentations of Initial Results From Phase 2 Studies of Atumelnant (CRN04894) in Congenital Adrenal ...

Are you searching for medications to treat 'Acromegaly'? Welcome to this page which serves as an archive for medications that are relevant to the treatment of Acromegaly. The page includes both ...

According to a recent report by Market.us, the Global Acromegaly Treatment Market size is expected to be worth around USD 3.4 Billion by 2033 from USD 1.6 Billion in 2023, growing at a CAGR of 7.7% ...

In patients with cured or controlled acromegaly prevalence of colonic diverticula is double that seen in controls (37% versus 19%), according to a Dutch research group. This novel finding “adds ...

Mutations in the aryl hydrocarbon receptor interacting protein gene (AIP) are seen in a minority (15%) of FIPA families and half of homogeneous acromegaly families have AIP mutations. Most AIP ...

Initial Data from Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia to be Presented, Along with Initial Findings from Phase 1b/2a ...

In a report released today, Jonathan Wolleben from JMP Securities reiterated a Buy rating on Crinetics Pharmaceuticals (CRNX – Research ...